Product News: Waters Full Spectrum Molecular Imaging and ACQUITY UPLC System Each Recognized at Pittcon 2015

12 Mar 2015

Waters Corporation has announced that both its new full spectrum molecular imaging system and its ACQUITY® UltraPerformance LC® (UPLC®) Technology received awards at the 2015 Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy.


Introduced this week, the Waters® full spectrum molecular imaging system was honored with the Pittcon Editors' Silver award for the most innovative product at Pittcon.

Additionally, the ACQUITY UltraPerformance LC Technology was recognized with the SelectScience Reviewers’ Choice Award, for the product with the best customer reviews and ratings on SelectScience, a leading online resource for the global scientific community.


Full Spectrum Molecular Imaging System

The full spectrum molecular imaging system is the first system ever to allow scientists to access enhanced matrix-assisted laser desorption ionization (MALDI) and desorption electrospray ionization (DESI) with ion mobility separation (IMS) in a single mass spectrometry platform.

Based on the Waters SYNAPT® G2-Smass spectrometer, the imaging capabilities of the new full spectrum molecular imaging system enable research laboratories to pinpoint with greater specificity the distribution of large and small molecules within tissue samples. Information derived from imaging experiments can greatly benefit cancer, cardiovascular and neuro-degenerative research by measuring the distribution of molecules in cells and tissues. MS imaging also allows researchers to identify different tissue types based on their molecular composition.

“We are honored by the Pittcon editors' recognition,” said Dr.Jeff Mazzeo, Sr. Director, Health Sciences, Waters Division. "By combining MALDI with DESI and ion mobility on the same instrument, Waters brings molecular imaging to a new level. We are committed to giving cell biologists, biochemists, clinical researchers and analytical scientists the tools they need to obtain a maximum amount of information to advance their research into human health. The new full spectrum molecular imaging system combines and optimizes Waters' mass spectrometry technologies to deliver a level of detail and molecular information beyond that of any individual imaging technique."

Waters plans to begin shipments of its full spectrum molecular imaging system in the third quarter of 2015.



First introduced in 2004, the ACQUITY UPLC System is acclaimed for its enhanced speed, resolution and sensitivity, while also improving the quality of results. By outperforming traditional or optimized HPLC, the ACQUITY UPLC System allows chromatographers to work at higher efficiencies with a much wider range of linear velocities, flow rates, and backpressures.

"We are tremendously proud that the ACQUITY UPLC System was recognized with the Reviewers’ Choice Award. This award is particularly significant because it is decided on by the scientific community, whose success is Waters’ ultimate mission,” said Ian King Ph.D., Vice President, Separations Technology, Waters Division. “Whether you work in methods development or quality assurance, drug discovery or food safety testing, UPLC Technology is proven to provide measurable scientific and business benefits.”

UPLC Technology, which has been adopted successfully in laboratories around the world for the most demanding separations, is highly robust, dependable, and reproducible. What differentiates the holistic design of ACQUITY UPLC systems is Waters’ patented 1.7 micron hybrid particle chemistry.

The ACQUITY UPLC System was a Pittcon Editor’s Gold Award winner in 2004.